Filing Details
- Accession Number:
- 0001209191-23-016703
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-07 16:07:15
- Reporting Period:
- 2023-03-03
- Accepted Time:
- 2023-03-07 16:07:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1124140 | Exact Sciences Corp | EXAS | Services-Medical Laboratories (8071) | 204782291 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1263312 | A Jacob Orville | C/O Exact Sciences Corp. 5505 Endeavor Lane Madison WI 53719 | General Manager, Screening | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-03-03 | 5,000 | $65.00 | 11,423 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 546 | Indirect | Held in 401(k) Plan |
Footnotes
- The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan entered into in November 2022.
- In addition to the shares of Common Stock reported on this Form 4, which total 11,969 shares, Mr. Orville also holds, in the aggregate, an additional 43,869 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
Billionaire Hedge Funds
